New study: SARS-CoV-2 doesn’t just lower white cell counts - it reshapes the T-cell landscape. Both the numbers and the quality of T-cells drop, especially in older and severely ill patients. And this has consequences. 🧵
Acute COVID-19 = a blow to T-cells. Patients had markedly lower absolute numbers of T-lymphocytes (CD4+, CD8+, naive and memory) compared to healthy controls. Classic lymphopenia - COVID cuts into the immune arsenal from the start. The immune system starts the fight with half its arsenal already gone.
Severity mirrors depth of the crash. The sickest patients had the lowest lymphocyte counts, especially CD8+ and naive T-cells. The steeper the disease, the deeper the T-cell depletion.
Age makes it worse. Naive CD8+ T-cells declined with age, the ratio of naive (CD45RA+) to memory (CD45RO+) T-cells also dropped in older patients. This reflects thymic shrinkage - older patients enter infection already depleted.
Functional subsets down too. CD4+CD28+ and CD8+CD28+ cells - key for strong activation and expansion - were reduced, pointing to exhaustion or dysfunction. Without CD28 co-signal, T-cells can recognize the virus but fail to switch on their turbo mode.
Treg paradox. Regulatory T-cells were relatively higher in proportion, but absolutely lower in number among the most severe cases. Smaller pie, bigger slice. The result? Immune imbalance - suppression and deficiency at once.
Antigen exposure pushes naive cells into memory. COVID drives a shift from naive (CD45RA+) to memory (CD45RO+) T-cells. Quick response today, but it burns tomorrow’s capacity - a costly trade-off in immunity!
CD8+ hit is critical. These are the main killers of infected cells, their loss in severe cases likely undermines viral control and fuels hyperinflammation.
CD28 signaling matters. Without costimulation, recognition doesn’t translate into full activation.
Put it together = the risk triad.
Age + loss of naive CD8 + fewer CD28+ T-cells = a recipe for severe disease. This biology explains why some patients spiral while others cope.
A T-cell panel (CD3, CD4, CD8 counts, naive/memory ratios, CD28 subsets) could help identify high-risk patients early - before their immune system fully crashes.
For older and immunocompromised, infection prevention is not optional. They enter COVID already disadvantaged, the virus then cuts away the last safety net.
But he warning is twofold.
In the elderly, COVID can wipe out the last reserve of naive T-cells, leaving them with little capacity to face new threats.
In children, each infection burns part of a vast reserve. It may not hurt today, but repeated hits could tax tomorrows immunity!
Public health.
Older and immunosuppressed individuals start from a worse baseline; infection then carves away what’s left. Prevention of infection is crucial, not optional! @szupraha @ZdravkoOnline
Sum:
Acute SARS-CoV-2 infection, especially in older or critically ill patients slashes both the quantity and quality of T-cells, with depletion of naive CD8 and CD28+ subsets and a skew toward memory phenotypes.
Limits.
Small sample (60 patients), single center, Omicron era. No long-term follow-up - unclear if and how quickly T-cell numbers recover. llmited control for time symptom onset, vacc/infection history, medications, comorbidities - all of which affect lymphocytes.
Lin et al. 2025, Study of Peripheral Blood T-Lymphocytes and Their Subpopulations in Patients with COVID-19, Biochemistry Research International. onlinelibrary.wiley.com/doi/epdf/10.11…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
SARS-CoV-2 can turn our own defenders into traitors.
A study in Sci Transl Med, 2025 shows the virus drives neutrophils into PMN-MDSCs cells that don’t fight, but suppress T cells.🧵
Instead of attacking the virus, these neutrophils hit the brakes on adaptive immunity.
T cells divide less, signal less.
The immune response collapses from within - right when it should be gaining strength.
And this is not just correlation.
Simply exposing neutrophils to SARS-CoV-2 in vitro was enough to reprogram them.
Contact with viral particles or proteins alone triggered the shift into PMN-MDSCs.
The virus can actively manipulate immunity from the start - not just passively ride the inflammation.
What wakes up Epstein-Barr virus (EBV) in Long COVID?
Most of us carry EBV silently for life.
But in Long COVID, EBV often wakes up - fatigue, brain fog, immune disruption.
Why? A new study just tested the main suspects🧵
The authors looked at 3 possibilities:
direct effect of SARS-CoV-2 on EBV+ cells
indirect effect via inflammation from infected cells
metabolic changes (esp heme)
Direct effect.
They infected EBV+ epithelial cells with SARS-CoV-2.
Result - the coronavirus replicates, but EBV stays asleep.
Interpretation - SARS-CoV-2 alone does not wake EBV.
Imagine a school year where 4 out of 5 students and staff get sick with a respiratory infection.
That’s not a dystopia.
That’s what a new study just found in a large US school district.🧵
816 children and staff were followed from November 2022 to May 2023.
They self-collected nasal swabs, reported symptoms, and were tracked week after week.
Result.
85% had at least one virus detected
80% had at least one acute respiratory illness (ARI)
(sic!)
New mega–meta-analysis on #LongCOVID ever prevalence.
Long COVID has affected 36% of people after a COVID-19 infection worldwide.
South America: 51%
Europe: 39%
Asia: 35%
USA: 29%🧵
Important note.
This 36% is “ever prevalence” - the share of people who at any point during follow-up had symptoms lasting ≥2 months after infection.
It does not mean they all still have symptoms today. Current prevalence is lower (eg 9% of US adults).
Why 2 months?
Different studies used different definitions of long COVID (WHO = 3 months, NASEM = 3 months, others = 2 months). To include the widest possible dataset, this meta-analysis defined long COVID as ≥1 new or persistent symptom lasting ≥2 months after infection.
A new Dutch study in BMJ Open 2025 followed people 2 years after COVID-19.
Even among those never hospitalized, 43% still had persistent symptoms.
This is a massive population-level impact.🧵
Hospitalized patients had higher prevalence of post-COVID (65%).
But they are a fraction of all infections.
The real burden comes from the huge group of mild cases!
The CORFU study = Corona Follow Up.
4,200 participants, 7 patient cohorts + controls.
Follow up at 3, 6, 12, 18, and 24 months.
New study in COVID (MDPI) followed 297 people 3 years after a single COVID-19 infection.
Key message: cognitive performance did not return to normal. Even one infection left measurable deficits🧵
Participants.
Mild - 101
Moderate (hospitalized) - 101
Severe (ICU, hypoxia) - 95
These were infections from the era of the original virus & Alpha variant (up to 2021). Omicron was not yet circulating.
Scores after 3 years (higher = better).
Divided attention: 44.5 - 36.1 - 27.3
Working memory: 10.6 - 9.3 - 9.0
Executive control: 9.0 - 7.6 - 7.5
Verbal fluency: 14.6 - 14.3 - 12.2
Recognition memory: 23.9 - 23.2 - 21.6
Trend is clear: more severe illness = greater cognitive loss.